Neoadjuvant Chemotherapy (NAC)

DRUG2 trials

Sponsors

The University of Texas Health Science Center, Houston

Conditions

Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)

Phase 2

EUS-RFA PANCARDINAL-1 Trial

RecruitingNCT04990609

The University of Texas Health Science Center, HoustonPancreatic Ductal Adenocarcinoma (PDAC)

Start: 2021-08-13End: 2028-05-30Target: 60Updated: 2026-07-29

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

RecruitingNCT06831136

The University of Texas Health Science Center, HoustonPancreatic Ductal Adenocarcinoma

Start: 2025-03-26End: 2030-01-20Target: 24Updated: 2025-09-10